Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma
MZL is predominantly seen in middle-aged and elderly patients and is a specific indolent B-cell lymphoma, with MALT lymphoma being the most common subtype. Achieving CR after induction therapy significantly prolongs survival in MZL patients. Compared to R ± chemotherapy, G ± chemotherapy achieves a higher CRR in high tumor burden MZL patients. In the era of immunotherapy, POD24 is an independent prognostic factor for MZL.
Authors
- Z Y Li (ORCID: https://orcid.org/0000-0002-9421-0513)
- Ou Bai (ORCID: https://orcid.org/0000-0003-4066-9473)
- Haotian Wang (ORCID: https://orcid.org/0000-0002-0879-9123)
- Ying Zhang (ORCID: https://orcid.org/0000-0002-2563-5606)
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.3389/fimmu.2024.1466859
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- People's Government of Jilin Province
- Department of Finance of Jilin Province